These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 11979841

  • 1. [Continuation of acid suppression therapy after H. pylori eradication].
    Takahashi M, Kuwayama H.
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():531-5. PubMed ID: 11979841
    [No Abstract] [Full Text] [Related]

  • 2. [Intractable ulcer].
    Yoshida Y, Miyatani H, Tokuyama T, Hirakawa R.
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():583-6. PubMed ID: 11979851
    [No Abstract] [Full Text] [Related]

  • 3. [Peptic ulcer in the elderly].
    Watanabe T, Chiba T.
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():603-7. PubMed ID: 11979855
    [No Abstract] [Full Text] [Related]

  • 4. [H. pylori eradication therapy and natural history of peptic ulcer].
    Haruma K, Kamada T, Kusunoki H.
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():49-53. PubMed ID: 11979833
    [No Abstract] [Full Text] [Related]

  • 5. [Current role of acid suppressants in the treatment of peptic ulcer disease].
    Takeda H.
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():371-6. PubMed ID: 11979809
    [No Abstract] [Full Text] [Related]

  • 6. [The outline of medical treatment of peptic ulcer].
    Nakamura T.
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():365-70. PubMed ID: 11979808
    [No Abstract] [Full Text] [Related]

  • 7. [Proton-pump inhibitors versus H2-receptor antagonists in triple therapy for Helicobacter pylori eradication].
    Kanayama S.
    Nihon Rinsho; 1999 Jan; 57(1):153-6. PubMed ID: 10036954
    [Abstract] [Full Text] [Related]

  • 8. [Dual therapy for Helicobacter pylori resistance to anti microbial agents].
    Fu HY, Kawano S, Tanimura H.
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():423-6. PubMed ID: 11979819
    [No Abstract] [Full Text] [Related]

  • 9. [Eradication of Helicobacter pylori and use of antisecretory drugs--a population based study].
    Lassen AT, Hallas J, Schaffalitzky de Muckadell OB.
    Ugeskr Laeger; 2004 Sep 20; 166(39):3405-7. PubMed ID: 15515395
    [No Abstract] [Full Text] [Related]

  • 10. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
    Bardou M.
    Rev Prat; 2001 Apr 15; 51(7):789-95. PubMed ID: 11387678
    [No Abstract] [Full Text] [Related]

  • 11. Proton pump inhibitors: cost-effective agents for management of reflux-induced esophagitis.
    Gregor JC.
    Am J Manag Care; 2000 Aug 15; 6(8):934-5. PubMed ID: 11186505
    [No Abstract] [Full Text] [Related]

  • 12. Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.
    Fennerty MB.
    Am J Gastroenterol; 1998 Jan 15; 93(1):2-3. PubMed ID: 9448162
    [No Abstract] [Full Text] [Related]

  • 13. Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle.
    Scarpignato C.
    Dig Liver Dis; 2005 Jul 15; 37(7):468-74. PubMed ID: 15893968
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.